Snowden Capital Advisors’s Arcturus Therapeutics ARCT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-19,660	Closed	-$479K	–	1217
2024 Q2	$479K	Buy	19,660 +533	+3%	+$16.2K	0.01%	775
2024 Q1	$646K	Buy	19,127 +7,502	+65%	+$266K	0.02%	648
2023 Q4	$367K	Buy	11,625 +2,248	+24%	+$53.4K	0.01%	837
2023 Q3	$240K	Hold	9,377	–	–	0.01%	940
2023 Q2	$269K	Hold	9,377	–	–	0.01%	998
2023 Q1	$225K	Sell	9,377 -6,489	-41%	-$116K	0.01%	1041
2022 Q4	$269K	Hold	15,866	–	–	0.01%	959
2022 Q3	$235K	Sell	15,866 -4,480	-22%	-$75.2K	0.01%	979
2022 Q2	$320K	Hold	20,346	–	–	0.01%	830
2022 Q1	$548K	Buy	20,346 +2,655	+15%	+$67.8K	0.02%	606
2021 Q4	$654K	Sell	17,691 -14,324	-45%	-$584K	0.03%	405
2021 Q3	$1.53M	Buy	32,015 +106	+0.3%	+$4.75K	0.08%	300
2021 Q2	$1.08M	Sell	31,909 -11,362	-26%	-$385K	0.05%	355
2021 Q1	$1.79M	Buy	43,271 +13,328	+45%	+$794K	0.1%	253
2020 Q4	$1.3M	Buy	29,943 +17,789	+146%	+$1.2M	0.09%	267
2020 Q3	$521K	Buy	+12,154	New	+$603K	0.04%	376